NEXGEL, INC. Cash Flow Statement
NXGL|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
NEXGEL, INC. used $4M in operating cash flow and negative free cash flow of $4M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.18 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$3.3M | -$3.2M | -$4.7M |
| Depreciation & Amortization | $436.0K | $226.0K | $112.0K |
| Operating Cash Flow | -$3.9M | -$3.2M | -$3.0M |
| Capital Expenditures | $443.0K | $696.0K | $96.0K |
| Free Cash Flow | -$4.3M | -$3.9M | -$3.1M |
| FCF Margin | -49.6% | -96.2% | -150.8% |